<i>In-silico, in-vitro</i> and <i>ex-vivo</i> evidence of combining silymarin phytopharmaceutical with piperine, and fulvic acid for enhancing its solubility and permeability.

Ralli, Tanya; Saifi, Zoya; Kumari, Amita; Aeri, Vidhu; Kohli, Kanchan

In-silico, in-vitro and ex-vivo evidence of combining silymarin phytopharmaceutical with piperine, and fulvic acid for enhancing its solubility and permeability.

Ralli, Tanya; Saifi, Zoya; Kumari, Amita; Aeri, Vidhu; Kohli, Kanchan.

Afiliación

Ralli T; Department of Pharmaceutics, School of Pharmaceutical Education & Research, New Delhi, India.
Saifi Z; Department of Pharmaceutics, School of Pharmaceutical Education & Research, New Delhi, India.
Kumari A; Indian Patent agent and TIFAC-DST Woman Scientist, Delhi, India.
Aeri V; Department of Pharmacognosy, School of Pharmaceutical Education & Research, New Delhi, India.
Kohli K; Department of Pharmaceutics, School of Pharmaceutical Education & Research, New Delhi, India.

Pharm Dev Technol ; 28(7): 595-610, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37342048

Asunto(s)

Silimarina; Silimarina/farmacología; Solubilidad; Permeabilidad; Disponibilidad Biológica

Palabras clave

Nonalcoholic fatty liver disease; anti-fibrotic; anti-inflammatory; fulvic acid; piperine; silymarin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Silimarina Idioma: En Revista: Pharm Dev Technol Asunto de la revista: FARMACIA Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google